[{"Assets_0_Q3_USD":140957000.0,"CommonStockSharesOutstanding_0_Q3_shares":36217920.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-31829000.0,"NetIncomeLoss_1_Q3_USD":-14745000.0,"NetIncomeLoss_3_Q3_USD":-41027000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":36202000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":36181000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":36202000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":36181000.0,"StockholdersEquity_0_Q3_USD":5427000.0,"EarningsPerShareBasic_1_Q3_USD":-0.41,"EarningsPerShareBasic_3_Q3_USD":-1.13,"EarningsPerShareDiluted_1_Q3_USD":-0.41,"EarningsPerShareDiluted_3_Q3_USD":-1.13,"Ticker":"ISEE","CIK":"1410939","name":"OPHTHOTECH CORP.","OfficialName":"IVERIC bio Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1851737728.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181102"}]